Tilray Brands, Inc. (NASDAQ:TLRY) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 9.
Analysts expect the Leamington, Canada-based company to report a quarterly loss at 2 cents per share, versus a year-ago loss of 1 cent per share. Tilray Brands projects quarterly revenue of $204.55 million, compared to $200.04 million a year earlier, according to data from Benzinga Pro.
On Aug. 28, Tilray Brands' medical division expanded its portfolio in Germany with three newly certified cannabis strains.
Shares of Tilray Brands fell 2.5% to close at $1.58 on Monday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
- Jefferies analyst Kaumil Gajrawala maintained a Buy rating and raised the price target from $1.5 to $2 on Aug. 25, 2025. This analyst has an accuracy rate of 50%.
- Zelman & Assoc analyst Pablo Zuanic reiterated a Neutral rating on July 29, 2025. This analyst has an accuracy rate of 52%.
- Piper Sandler analyst Michael Lavery maintained a Neutral rating and cut the price target from $2 to $1 on April 9, 2025. This analyst has an accuracy rate of 65%.
Considering buying TLRY stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
